Shiga toxin (Stx) is considered the main virulence factor in Shiga toxin-producing
Escherichia coli (STEC) infections. Previously we reported the expression of biologically active Stx by eukaryotic cells
in vitro and
in vivo following transfection with plasmids encoding Stx under control of the native bacterial promoter. Since
stx genes are present in the genome of lysogenic bacteriophages, here we evaluated the relevance of bacteriophages during STEC infection. We used the non-pathogenic
E. coli K12 strain carrying a lysogenic 933W mutant bacteriophage in which the
stx operon was replaced by a gene encoding the green fluorescent protein (GFP). Tracking GFP expression using an
In Vivo Imaging System (IVIS), we detected fluorescence in liver, kidney, and intestine of mice infected with the recombinant
E. coli strain after treatment with ciprofloxacin, which induces the lytic replication and release of bacteriophages.In addition, we showed that chitosan, a linear polysaccharide composed of D-glucosamine residues and with a number of commercial and biomedical uses, had strong anti-bacteriophage effects, as demonstrated
in vitro and
in vivo. These findings bring promising perspectives for the prevention and treatment of hemolytic uremic syndrome (HUS) cases.